← All organizations
Universidade Federal do Parana
Academic/HospitalWebsite ↗
Also known as: Antonio Stabelini Neto | Federal Technological University of Paraná | Federal University of Parana | Hospital de Clinicas da Universidade Federal do Parana | UFPR | Universidade Estadual do Oeste do Paraná | Universidade Federal do Paraná
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2006Last known activity
May 1, 2017
Timeline
1910s
- Jan 1, 1912
Universidade Federal do Parana— Founded
Drugs by trial phase (10 distinct, 6 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Dentin Sensitivity
- Endometrial Hyperplasia
- Eunuchism
- Hyperplasia
- Hypogonadism
- Leukemia
- Leukemia, Lymphoid
- Lymphoma
- Parasomnias
- Pelvic Organ Prolapse
- Periodontitis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Prolapse
- Sleep Initiation and Maintenance Disorders
- Sleep Wake Disorders
- Vaginitis
Recent trials (9)
- NCT03176537Overall official - principal investigatorPhase 4May 1, 2017
- NCT03176537Reponsible party - principal investigatorPhase 4May 1, 2017
- NCT03176537Lead sponsorPhase 4May 1, 2017
- NCT03343392CollaboratorPhase 3Jan 5, 2016
- NCT02364869CollaboratorN/AMay 1, 2015
- NCT03032848Reponsible party - principal investigatorPhase 4Nov 26, 2013
- NCT03032848Lead sponsorPhase 4Nov 26, 2013
- NCT01142258CollaboratorPhase 3Mar 1, 2010
- NCT00419081Overall official - principal investigatorPhase 2Jul 1, 2006
Details
- Founded
- Curitiba, BR Jan 1, 1912
- Last known activity
- May 1, 2017